Antonarakis, Emmanuel S; Park, Se Hoon; Goh, Jeffrey C; Shin, Sang Joon; Lee, Jae Lyun; Mehra, Niven; McDermott, Ray; Sala-Gonzalez, Núria; Fong, Peter C; Greil, Richard; Retz, Margitta; Sade, Juan Pablo; Yanez, Patricio; Huang, Yi-Hsiu; Begbie, Stephen D; Gafanov, Rustem Airatovich; De Santis, Maria; Rosenbaum, Eli; Kolinsky, Michael P; Rey, Felipe; Chiu, Kun-Yuan; Roubaud, Guilhem; Kramer, Gero; Sumitomo, Makoto; Massari, Francesco; Suzuki, Hiroyoshi; Qiu, Ping; Zhang, Jinchun; Kim, Jeri; Poehlein, Christian H; Yu, Evan Y, Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial, «JOURNAL OF CLINICAL ONCOLOGY», 2023, 41, pp. 3839 - 3859 [Scientific article]Open Access
Matteo Rosellini; Andrea Marchetti; Veronica Mollica; Alessandro Rizzo; Matteo Santoni; Francesco Massari, Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma, «NATURE REVIEWS. UROLOGY», 2023, 20, pp. 133 - 157 [Scientific article]Open Access
Marchetti, Andrea; Tassinari, Elisa; Rosellini, Matteo; Rizzo, Alessandro; Massari, Francesco; Mollica, Veronica, Prostate cancer and novel pharmacological treatment options - what's new for 2022?, «EXPERT REVIEW OF CLINICAL PHARMACOLOGY», 2023, 1, pp. 1 - 14 [Scientific article]
Rosellini, Matteo; Tassinari, Elisa; Marchetti, Andrea; Mollica, Veronica; Massari, Francesco, Re: Atezolizumab Plus Cabozantinib Versus Cabozantinib Monotherapy for Patients with Renal Cell Carcinoma After Progression with Previous Immune Checkpoint Inhibitor Treatment (CONTACT-03): A Multicentre, Randomised, Open-label, Phase 3 Trial, «EUROPEAN UROLOGY», 2023, 1, pp. 1 - 2 [Scientific article]
Tateo, Valentina; Mollica, Veronica; Rizzo, Alessandro; Santoni, Matteo; Massari, Francesco, Re: WHO Classification of Tumours, 5th Edition, Volume 8: Urinary and Male Genital Tumours, «EUROPEAN UROLOGY», 2023, 1, pp. 1 - 2 [Scientific article]
Santoni, Matteo; Myint, Zin W; Büttner, Thomas; Takeshita, Hideki; Okada, Yohei; Lam, Elaine T; Gilbert, Danielle; Küronya, Zsófia; Tural, Deniz; Pichler, Renate; Grande, Enrique; Crabb, Simon J; Kemp, Robert; Massari, Francesco; Scagliarini, Sarah; Iacovelli, Roberto; Vau, Nuno; Basso, Umberto; Maruzzo, Marco; Molina-Cerrillo, Javier; Galli, Luca; Bamias, Aristotelis; De Giorgi, Ugo; Zucali, Paolo Andrea; Rizzo, Mimma; Seront, Emmanuel; Popovic, Lazar; Caffo, Orazio; Buti, Sebastiano; Kanesvaran, Ravindran; Kopecky, Jindrich; Kucharz, Jakub; Zeppellini, Annalisa; Fiala, Ondřej; Landmesser, Johannes; Ansari, Jawaher; Giannatempo, Patrizia; Rizzo, Alessandro; Zabalza, Ignacio Ortego; Monteiro, Fernando Sabino M; Battelli, Nicola; Calabrò, Fabio; Porta, Camillo, Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study, «CANCER IMMUNOLOGY, IMMUNOTHERAPY», 2023, 72, pp. 2961 - 2970 [Scientific article]Open Access
Raschi E.; Comito F.; Massari F.; Gelsomino F., Relatlimab and nivolumab in untreated advanced melanoma: insight into RELATIVITY, «IMMUNOTHERAPY», 2023, 15, pp. 85 - 91 [Scientific article]
Matteo Santoni; Javier Molina-Cerrillo; Giorgio Santoni; Elaine T. Lam; Francesco Massari; Veronica Mollica; Giulia Mazzaschi; Bernardo L. Rapoport; Enrique Grande; Sebastiano Buti, Role of Clock Genes and Circadian Rhythm in Renal Cell Carcinoma: Recent Evidence and Therapeutic Consequences, «CANCERS», 2023, 15, Article number: 408 , pp. 1 - 10 [Scientific article]Open Access
Monteiro, Fernando Sabino Marques; Fiala, Ondřej; Massari, Francesco; Myint, Zin W; Kopecky, Jindrich; Kucharz, Jakub; Büttner, Thomas; Grande, Enrique; Bourlon, Maria Teresa; Molina-Cerrillo, Javier; Pichler, Renate; Buchler, Tomas; Seront, Emmanuel; Ansari, Jawaher; Bamias, Aristotelis; Bhuva, Dipen; Vau, Nuno; Porta, Camillo; Fay, Andre Poisl; Santoni, Matteo, Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study, «CLINICAL GENITOURINARY CANCER», 2023, 1, pp. 1 - 13 [Scientific article]
Melotti, Sofia; Ambrosi, Francesca; Franceschini, Tania; Giunchi, Francesca; Filippo, Giorgia Di; Franchini, Eugenia; Massari, Francesco; Mollica, Veronica; Tateo, Valentina; Bianchi, Federico Mineo; Colecchia, Maurizio; Acosta, Andres Martin; Lobo, João; Fiorentino, Michelangelo; Ricci, Costantino, TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis, «PATHOLOGY RESEARCH AND PRACTICE», 2023, 247, pp. 154540 - 154546 [Scientific article]Open Access
Mollica, Veronica; Tassinari, Elisa; Santoni, Matteo; Marchese, Paola Valeria; Giunchi, Francesca; Maloberti, Thais; Tateo, Valentina; Ricci, Costantino; Rosellini, Matteo; Marchetti, Andrea; Fiorentino, Michelangelo; Biase, Dario De; Massari, Francesco, TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab, «PATHOLOGY RESEARCH AND PRACTICE», 2023, 253, pp. 155008 - 155013 [Scientific article]
Nuvola, Giacomo; Mollica, Veronica; Massari, Francesco; Suárez, Cristina, The future of immunotherapy in advanced renal cell carcinoma: beyond PD-1/PD-L1 inhibitors, «IMMUNOTHERAPY», 2023, 1, pp. 1 - 6 [Scientific article]
Mollica, Veronica; Rizzo, Alessandro; Marchetti, Andrea; Tateo, Valentina; Tassinari, Elisa; Rosellini, Matteo; Massafra, Raffaella; Santoni, Matteo; Massari, Francesco, The impact of ECOG performance status on efficacy of immunotherapy and immune-based combinations in cancer patients: the MOUSEION-06 study, «CLINICAL AND EXPERIMENTAL MEDICINE», 2023, 1, pp. 1 - 11 [Scientific article]
Monteiro, Fernando Sabino Marques; Soares, Andrey; Rizzo, Alessandro; Santoni, Matteo; Mollica, Veronica; Grande, Enrique; Massari, Francesco, The role of immune checkpoint inhibitors (ICI) as adjuvant treatment in renal cell carcinoma (RCC): A systematic review and meta-analysis, «CLINICAL GENITOURINARY CANCER», 2023, 23, pp. 1 - 10 [Scientific article]
Fiala, Ondřej; Buti, Sebastiano; Takeshita, Hideki; Okada, Yohei; Massari, Francesco; Palacios, Georgia Anguera; Dionese, Michele; Scagliarini, Sarah; Büttner, Thomas; Fornarini, Giuseppe; Myint, Zin W; Galli, Luca; Souza, Vinicius Carrera; Pichler, Renate; De Giorgi, Ugo; Quiroga, María Natalia Gandur; Gilbert, Danielle; Popovic, Lazar; Grande, Enrique; Mammone, Giulia; Berardi, Rossana; Crabb, Simon J; Molina-Cerrillo, Javier; Freitas, Marcelo; Luz, Murilo; Iacovelli, Roberto; Calabrò, Fabio; Tural, Deniz; Atzori, Francesco; Küronya, Zsófia; Chiari, Rita; Campos, Saul; Caffo, Orazio; Fay, André P; Kucharz, Jakub; Zucali, Paolo Andrea; Rinck, José Augusto; Zeppellini, Annalisa; Bastos, Diogo Assed; Aurilio, Gaetano; Mota, Augusto; Trindade, Karine; Ortega, Cinzia; Sade, Juan Pablo; Rizzo, Mimma; Vau, Nuno; Giannatempo, Patrizia; Barillas, Allan; Monteiro, Fernando Sabino Marques; Dauster, Breno; Cattrini, Carlo; Nogueira, Lucas; de Carvalho Fernandes, Roni; Seront, Emmanuel; , Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study, «CANCER IMMUNOLOGY, IMMUNOTHERAPY», 2023, 1, pp. 1 - 18 [Scientific article]
